WuXi Biologics

Facility Spotlight: Let us help you realize your breakthrough biological treatment from concept to clinical trials and beyond, discovered, developed and manufactured here in the United States. Here’s a quick glimpse of our U.S.-based facilities and high-quality CMC development capabilities and services for biologics (e.g., monoclonal and bispecific antibodies, antibody drug conjugates, recombinant proteins and vaccines). https://lnkd.in/eyBYfwq8 #cmcdevelopment #biomanufacturing #drugdevelopment #biologics

Introducing WuXia™ RidGS, a cutting-edge solution for non-antibiotic cell line development. Based on the established WuXia technology platform, WuXia™ RidGS uses advanced ZFN technology to knock out the GS gene in CHO cells, delivering robust growth, exceptional expression levels (exceeding 6 g/L for mAbs), and stable long-term productivity. Free from the destabilizing effects of antibiotics, WuXia RidGS ensures product quality across mAbs and many other modalities. 🪁 Ready to elevate your biologics development? Learn more today: https://lnkd.in/e2ncaWQi #Biologics #CellLineDevelopment #CHOCells

Will you be attending PEGS Europe (November 5-7) in Barcelona, Spain? Jijie Gu, PhD, CSO at WuXi Biologics, will be speaking during the event on Thursday, November 7 at 12:15pm CET. Dr. Gu will present "Combining Primary, Secondary, and Tertiary Signals with Immune Cell Engagers to Supercharge Anti-Tumor Immunity". Our WuXi Biologics team will be available to discuss your R&D and drug discovery goals during the event. Contact us and we'll set up a convenient time to discuss your outsourcing or partnering needs. https://lnkd.in/gvNFGynY #PEGSEurope #Biologics #DrugDiscovery #Immunotherapy #BarcelonaEvents #Pharmaceuticals #R&D #LifeSciences #Biotech

When it comes to complex molecules, we believe in keeping your analytics simple. At WuXi Biologics, Analytical Sciences and Clinical Quality Control team up to provide unparalleled testing capacity across a wide range of biologics. With our global network of state-of-the-art labs, we deliver tailored solutions to your doorstep—no rigid service models. From method development to qualification and validation, we tailor every service to meet your needs, freeing you to focus on the intricate modalities that matter most. Ready to simplify your analytics? Let’s connect and find a solution. https://lnkd.in/ensHBRYQ #ComplexMolecules #AnalyticsSimplified #BiologicsTesting #MethodDevelopment #ValidationServices #ClinicalQualityControl #AnalyticaltTesting

Will you be attending PEGS Europe (November 5-7) in Barcelona, Spain? Jiansheng Wu, PhD, SVP, Head of CRO Services at WuXi Biologics, will be speaking on Wednesday, November 6 at 10am CET. Dr. Wu will present "Innovative Platforms for Producing Mini Proteins & T-Cell Related Therapeutic Targets". Our WuXi Biologics team will be available to discuss your R&D and drug discovery goals during the event. Contact us and we'll set up a convenient time to discuss your outsourcing or partnering needs. https://lnkd.in/gvNFGynY #PEGSEurope #BiotechConference #ProteinSciences #DrugDiscovery #BarcelonaEvents #PharmaInnovation #R&D #Biologics

We invite you to join our upcoming workshop, Biosafety, AS/QC Testing and Beyond: Advancing Testing Solutions for the Future, taking place on Friday, December 6, 2024 at Green Palace (Peacock Room 2, Matsushima 1-38-1, Edogawa-Ku, Tokyo) from 17:30 to 20:00, followed by a complimentary dinner banquet from 20:00 to 21:00. At this event, you’all have the opportunity to engage with our experts and explore cutting-edge topics. The seminar will cover topics ranging from biosafety testing overviews, next-generation sequencing (NGS), to successful ADC development through advanced analytical technologies, concluding with the banquet networking session. Don’t miss this opportunity to gain insights, network with professionals, and enjoy a free dinner - register now before seats fill up! https://lnkd.in/dGaXfbxW

Co-formulated drug products, containing two or more proteins (antibodies and/or hyaluronidase), are attractive options in the treatment of disease because these products hold the promise of better efficacy, higher efficiency and extended intellectual property rights.  However, there are only limited numbers of approved co-formulated biotherapeutics, partially due to the technical challenges in formulation development and establishment of appropriate analytical methods. At WuXi Biologics our expert team of drug product development scientists have the necessary experience and know-how to help you overcome these challenges and accelerate the development of these novel products to the clinic and beyond. Learn more at https://lnkd.in/ewyF7H_s #drugproduct #bioprocess #biologics #biopharma #biopharmaceuticals

Break free from single-site dependency and balance risk for drug substance and drug product. Our dual-site manufacturing taps into a global network to maintain supply, accelerate time-to-market, and ensure quality. Delays at one site are seamlessly managed with capacity at another, enabling uninterrupted, scalable cGMP manufacturing with minimal risk. Dual sourcing delivers these benefits to your doorstep, reducing geographic limitations, cutting lead times, and enhancing reliability. We’re where you need us, when you need us. Let’s get started: https://lnkd.in/deEbFvb6.

The MSAT (Manufacturing Science and Technology) team at WuXi Biologics Germany is specialized in tech transfer, process improvement and process validation for both upstream and downstream processing. Key highlights of our approach include: • Small-Scale Experiments: Conducting studies from 3L to 250L scale to support tech transfer and facility fit. • Design of Experiments: A systematic methodology that optimizes processes for improved process reliability. • Global Support for Tech Transfers: Acting as the primary contact for clients during process transfers, facilitating smooth transitions. By utilizing our expertise and methodologies, we drive production reliability and efficiency, ensuring successful outcomes for all projects. #Pharma #Biologics #Manufacturing #TechTransfer #ProcessValidation #WuXiBiologics